<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceuticals-13-00313">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Chin</surname>
    <given-names>Y.W.</given-names>
   </name>
   <name>
    <surname>Jee</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Keum</surname>
    <given-names>Y.-S.</given-names>
   </name>
   <name>
    <surname>Jeong</surname>
    <given-names>Y.-J.</given-names>
   </name>
  </person-group>
  <article-title>Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13</article-title>
  <source>Bioorg. Med. Chem. Lett.</source>
  <year>2012</year>
  <volume>22</volume>
  <fpage>4049</fpage>
  <lpage>4054</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.04.081</pub-id>
  <pub-id pub-id-type="pmid">22578462</pub-id>
 </element-citation>
</ref>
